연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
725. Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy.
Jung Y, Park J, Kim TY, Park JH, Jong HS, Im SA, Robertson KD, Bang YJ, Kim TY.
J Mol Med. 2007 Oct;85(10):1137-48.
Link
724. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.
Lee KH, Min HS, Han SW, Oh DY, Lee SH, Kim DW, Im SA, Chung DH, Kim YT, Kim TY, Heo DS, Bang YJ, Sung SW, Kim JH.
Lung Cancer. 2007 Nov 22
Link
723. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
BMC Cancer. 2007 Apr 12;7:63.
Link
722. Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer.
Keam B, Im SA, Kim HJ, Oh DY, Kim JH, Lee SH, Chie EK, Han W, Kim DW, Moon WK, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
BMC Cancer. 2007 Nov 1;7(1):203
Link
721. A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer.
Kim YJ, Im SA, Kim HG, Oh SY, Lee KW, Choi IS, Oh DY, Lee SH, Kim JH, Kim DW, Kim TY, Kim SW, Heo DS, Yoon YB, Bang YJ.
Ann Oncol. 2008 Jan;19(1):99-103. Epub 2007 Sep 9
Link
720. Development of 3-D nanofibrous fibroin scaffold with high porosity by electrospinning: implications for bone regeneration.
Ki CS, Park SY, Kim HJ, Jung HM, Woo KM, Lee JW, Park YH.
Biotechnology Letters. Epub 2007 Nov. 1
Link
719. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition.
H Jung, K P Lee, S J Park, J H Park, Y-S Jang, S-Y Choi, J-G J, K Jo, D Y Park, J H Yoon, J-H Park, D-S Lim, Y-K Park, G-R Hong, C Choi, J W Lee, H J Hong, S Kim, and Y W Park.
Oncogene. 2007 Oct 29 [Epub ahead of print]
Link
718. DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma.
Kim T-Y, Lee J.W, Kim H-P, Jong H-S, Kim T-Y, Jung M., and Bang Y-J.
Biochem. Biophys. Res. Commun. 2007 Mar 30;355(1):72-77
Link
717. Caffeic acid and its synthetic derivative CADPE suppress tumor angiogenesis by blocking STAT3-mediated VEGF expression in human renal carcinoma cells.
Jung JE, Kim HS, Lee CS, Park DH, Kim YN, Lee MJ, Lee JW(이정원), Park JW, Kim MS, Ye SK, Chung MH.
Carcinogenesis. 2007 Aug;28(8):1780-1787
Link
716. C6 glioma cell insoluble matrix components enhance IFN-γ-stimulated iNOSNO production in BV2 microglial cells.
Yoon-Jung Kim, So-Young Hwang, Ji-Sun Hwang,Jung Weon Lee, Eok-Soo Oh, Inn-Oc Han.
The Journal of Biological Chemistry. 2007 Epub Nov. 2.
Link